Optimization of pyrimidinyl- and triazinyl-amines as non-nucleoside inhibitors of HIV-1 reverse transcriptase
- 1 November 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (21), 5664-5667
- https://doi.org/10.1016/j.bmcl.2006.08.037
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptaseBioorganic & Medicinal Chemistry Letters, 2006
- Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptaseBioorganic & Medicinal Chemistry Letters, 2005
- Molecular modeling of organic and biomolecular systems using BOSS and MCPROJournal of Computational Chemistry, 2005
- Potential energy functions for atomic-level simulations of water and organic and biomolecular systemsProceedings of the National Academy of Sciences, 2005
- The evolution of synthetic oral drug propertiesBioorganic & Medicinal Chemistry Letters, 2005
- Synthetic Study of Substituted ArylsulfonylphenylbenzamidesSynthetic Communications, 2005
- Novel Use of a Guanosine Prodrug Approach To Convert 2',3'-Didehydro-2',3'-Dideoxyguanosine into a Viable Antiviral AgentAntimicrobial Agents and Chemotherapy, 2002
- Prediction of drug solubility from structureAdvanced Drug Delivery Reviews, 2002